The Supreme Court denied the plaintiffs’ Petition for a Writ of Certiorari in Clayworth v. Pfizer, Inc., et al., in which the plaintiffs sought Supreme Court review of a California state antitrust action in which the plaintiffs accused fifteen pharma companies and their trade association of conspiring to fix prices in violation of the Cartwright Act, California’s antitrust statute, by using Canadian drug prices as a floor and preventing cross-border importation. The rejection ended nine years of litigation, upholding a 2012 decision by the California Court of Appeal that affirmed a 2011 grand of summary judgment in favor of the defendants.
Kaye Scholer’s Antitrust Practice Group Co-Chair Saul P. Morgenstern argued summary judgment in the trial court on behalf of the moving defendants, and Los Angeles based partner Aton Arbisser argued in the California Court of Appeal. The litigation team included Bryant Delgadillo (LA counsel), Karin E. Garvey (NY counsel), Amanda Myers (LA Associate) and Michael Schenk (LA paralegal).
Also of Interest
- Benchmark Litigation Recognizes Kaye Scholer Practices and Partners Nationwide October 24, 2016 • Recognitions
- GIR 100 Names Kaye Scholer a World Leader in Cross-Border Investigations October 10, 2016 • Recognitions
- Antitrust Jurisprudence in the Second Circuit October 1, 2016 • Articles
- NLJ Names Shores as Antitrust Trailblazer September 27, 2016 • Recognitions
- Morgenstern, Patterson Assess Second Circuit’s Antitrust Legacy in Fordham Law Review September 19, 2016 • Articles
- Arbisser Featured in The Recorder and Law360... September 7, 2016 • Media Mentions
- Consumer Products: Adapting to Innovation Fall 2016 • Reports / Newsletters
- ILS and Zinsser Analytic Shareholders Sell to Gardner Denver Medical September 2, 2016 • Client Successes
- Kaye Scholer Advises Veracen on Merger of Equals with Turner Investments August 31, 2016 • Client Successes